Hofmanis, J.; Tretjakovs, P.; Svirskis, S.; Gersone, G.; Hofmane, D.; Rozenberga, U.; Blumfelds, L.; Bahs, G.; Lejnieks, A.; Mackevics, V.
Prognostic Utility of Circulating Growth Factors in Aortic Valve Stenosis: A Pilot Study. Medicina 2021, 57, 78.
https://doi.org/10.3390/medicina57010078
AMA Style
Hofmanis J, Tretjakovs P, Svirskis S, Gersone G, Hofmane D, Rozenberga U, Blumfelds L, Bahs G, Lejnieks A, Mackevics V.
Prognostic Utility of Circulating Growth Factors in Aortic Valve Stenosis: A Pilot Study. Medicina. 2021; 57(1):78.
https://doi.org/10.3390/medicina57010078
Chicago/Turabian Style
Hofmanis, Juris, Peteris Tretjakovs, Simons Svirskis, Gita Gersone, Dace Hofmane, Ulla Rozenberga, Leons Blumfelds, Guntis Bahs, Aivars Lejnieks, and Vitolds Mackevics.
2021. "Prognostic Utility of Circulating Growth Factors in Aortic Valve Stenosis: A Pilot Study" Medicina 57, no. 1: 78.
https://doi.org/10.3390/medicina57010078
APA Style
Hofmanis, J., Tretjakovs, P., Svirskis, S., Gersone, G., Hofmane, D., Rozenberga, U., Blumfelds, L., Bahs, G., Lejnieks, A., & Mackevics, V.
(2021). Prognostic Utility of Circulating Growth Factors in Aortic Valve Stenosis: A Pilot Study. Medicina, 57(1), 78.
https://doi.org/10.3390/medicina57010078